.It is actually an uncommonly active Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bic...
.Atea Pharmaceuticals' antiviral has fallen short an additional COVID-19 trial, yet the biotech stil...
.Neurocrine Biosciences' mental illness course pivot has actually fallen short. The biotech was actu...
.Sanofi has actually made an overdue entry to the radioligand event, paying 100 thousand europeans (...
.After F2G's very first attempt to obtain a new class of antifungal to market was thwarted by the FD...
.Moderna has sworn to cut R&D spending through $1.1 billion by 2027. The decision to retract the ...
.Just four months after Sanofi wager $80 million in beforehand cash money on Pivot Rehabs' losmapimo...
.Cancer business Oncternal Rehabs is folding all its own scientific trials and also laying off perso...
.Roche is holding out chances that its injectable being overweight prospect could ultimately show 25...
.Novo Nordisk has lifted the top on a stage 1 trial of its oral amylin as well as GLP-1 receptor co-...